Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: J Am Acad Child Adolesc Psychiatry. 2020 Feb 29;60(2):274–285. doi: 10.1016/j.jaac.2020.02.007

Table 1.

Participant Characterization per Group

ASD (N = 50) TD (N = 43) Statistical Comparison
Mean (SD) Range Mean (SD) Range
Gender 8 female participants 5 female participants χ2(1) = 0.37, p = 0.544
Handedness 9 left 5 left χ2(1) = 0.73, p = 0.392
Age (years) 13.5 (2.7) 7.4–18.0 13.6 (2.6) 8.1–17.7 t(91) = −0.17, p = 0.865
WASI-II
 Verbal IQ 100.5 (17.6) 59–147 106.8 (9.2) 87–127 t(91) = −2.19, p = 0.032
 Non-verbal IQ 105.3 (18.2) 53–140 104.5 (13.4) 62–129 t(91) = 0.24, p = 0.810
 Full-Scale IQ 103.3 (16.9) 61–141 106.1 (10.6) 79–126 t(91) = −0.97, p = 0.333
RMSD 0.06 (0.03) 0.02–0.13 0.06 (0.03) 0.02–0.13 t(91) = 0.57, p = 0.569
ADOSa
 Social interaction 7.8 (2.6) 4–14
 Communication 4.0 (1.7) 0–8
 Rep./Restricted 2.2 (1.5) 0–5
ADI-Rb
 Social interaction 18.2 (4.6) 6–28
 Communication 13.2 (5.0) 2–24
 Rep. behaviors 5.8 (2.2) 1–12
Psychotropic medication use 26 reported
Comorbiditiesc 20 reported
SRS
 Awareness 71.7 (14.1) 39–97 44.2 (9.2) 30–73 t(90) = 10.81, p < 0.001
 Cognition 75.9 (11.8) 45–99 43.6 (6.2) 36–56 t(90) = 16.28, p < 0.001
 Communication 80.8 (11.3) 62–110 43.6 (5.5) 36–60 t(90) = 19.43, p < 0.001
 Motivation 75.6 (11.9) 56–104 45.9 (5.6) 37–56 t(90) = 15.05, p < 0.001
 ASD mannerisms 86.4 (15.8) 58–126 44.6 (5.9) 40–65 t(90) = 16.31, p < 0.001

Note: ADI-R = Autism Diagnostic Interview-Revised; ADOS = Autism Diagnostic Observation Schedule; ASD = autism spectrum disorder; IQ = intelligence quotient; Rep. = repetitive; RMSD = root mean squared displacement; SD = standard deviation; SRS = Social Responsiveness Scale; TD = typically developing; WASI-II = Wechsler Abbreviated Scale of Intelligence, 2nd edition.

a

Subdomain data not available for 1 participant with ASD.

b

Subdomain data not available for 1 participant with ASD.

c

Comorbid psychiatric conditions reported in the ASD group include attention-deficit/hyperactivity disorder (n = 11), depression (n = 5), and anxiety (n = 12); 6 out of 20 participants reported more than one diagnosed comorbid condition.